Filing Details
- Accession Number:
- 0000899243-18-023935
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-09-06 17:00:21
- Reporting Period:
- 2018-09-04
- Accepted Time:
- 2018-09-06 17:00:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1552451 | Myokardia Inc | MYOK | Pharmaceutical Preparations (2834) | 455500552 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1691494 | Marc Semigran | C/O Myokardia, Inc. 333 Allerton Avenue South San Francisco CA 94080 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-09-04 | 41,400 | $15.95 | 41,400 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-09-04 | 41,400 | $59.49 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-09-05 | 3,600 | $15.95 | 3,600 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-09-05 | 3,600 | $60.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-09-04 | 41,400 | $0.00 | 41,400 | $15.95 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-09-05 | 3,600 | $0.00 | 3,600 | $15.95 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 133,600 | 2026-11-30 | No | 4 | M | Direct | |
| 130,000 | 2026-11-30 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- 25% of the shares subject to the option vested and became exercisable on December 1, 2017 and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
